Story thread · 5 reports / 5 sources
Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trials
endpts.com · 3h · first report
How the coverage leans
Across 5 sources · syndicated copies counted once
Definium Therapeutics said Wednesday its oral LSD candidate has passed a late-stage study in generalized anxiety disorder (GAD), not even two months after reporting trial success for the same asset in a severe form of ...
The coverage
- This LSD-Based Drug Just Scored Again. Definium Stock Soars.
investors.com · 1h
- STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial
statnews.com · 2h
- Definium succeeds in late-stage trial for LSD-derived psychiatric therapy
seekingalpha.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.